Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Structure of an engineered dimeric human ribonuclease (foreground) which has been altered to both facilitate targetting to cancer cells and to render it insensitive to its natural cytosolic inhibitor (shown in background). For more details, see Suzuki et al. p265 and Wagner and Lipovsek, p227 Illustration by Ken Eward (BioGrafx,Mount Vernon, Ohio).